Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BIOCHING CAPITAL

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 16
Average round size
info
The average size of a deal this fund participated in
$6M
Portfolio companies 15
Rounds per year 2.00
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.06
Key employees Soon

Areas of investment

  • Medical Device
  • Health Care
  • Biotechnology
  • Medical
  • Health Diagnostics

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of BIOCHING CAPITAL:
Typical Co-investors
BIOCHING CAPITAL is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after BIOCHING CAPITAL:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Argonaut Holdings Detroit, Michigan, United States
Arthurian Life Sciences England, London, United Kingdom
Axel Johnson New York, New York, United States
Axiometrics Dallas, Texas, United States
Binhai Capital China, Guangdong, Tianjin
Gateway Partners Central, Central Region, Singapore
Growth Catalyst Partners Chicago, Illinois, United States
Hengtai Securities China, Hohhot, Nei Mongol
Longmont Capital, Ltd Houston, Texas, United States
Natural Sciences and Engineering Research Council of Canada (NSERC) -
NPIF - FW Capital Debt Finance Birmingham, England, United Kingdom
Omni Prime China, Shanghai
Osbon Capital Management Boston, Massachusetts, United States
Polymath Ventures Buenaventura, Colombia, Valle del Cauca
Pulte Home Corp Atlanta, Georgia, United States
Ranwa Technologies Co. -
RTL Ventures Hilversum, Noord-Holland, The Netherlands
Ruiqi Investment China, Hong Kong, Hong Kong Island
VinaCapital Ventures Chicago, Illinois, United States
Xterra Inc California, San Francisco, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Aoli Biotechnology

Biopharma
Biotechnology
29 Jan 2024 Shenzhen, Guangdong, China

Salus BioMed

Bioinformatics
Biotechnology
Genetics
Medical
01 Dec 2023 Shenzhen, Guangdong, China

Yinghe Brain Science

Health Care
Medical
Medical Device
$100M23 Jan 2023 Shenzhen, Guangdong, China

Dameng Bio

Health Diagnostics
Medical
Medical Device
17 Dec 2021 Shenzhen, Guangdong, China

Seppo Biotechnology

Biotechnology
Health Care
Medical Device
01 Jan 2021 Shenzhen, Guangdong, China

celula

Clinical Trials
Manufacturing
Medical Device
$463K09 Oct 2018 Qingyang District, Sichuan, China

Channel Biotechnology

Biotechnology
Health Care
Medical Device
01 Jan 2018 Shenzhen, Guangdong, China

AgTech
Biotechnology
Genetics
Test and Measurement
01 Nov 2016 Shanghai, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BIOCHING CAPITAL?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 16
Average round size 6M
Rounds per year 2.00
Peak activity year 2021
Lead investments 0
Follow on index 0.06
Group Appearance index 0.38

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Aoli Biotechnology

Biopharma
Biotechnology
29 Jan 2024 Shenzhen, Guangdong, China

Salus BioMed

Bioinformatics
Biotechnology
Genetics
Medical
01 Dec 2023 Shenzhen, Guangdong, China

Yinghe Brain Science

Health Care
Medical
Medical Device
$100M23 Jan 2023 Shenzhen, Guangdong, China

Dameng Bio

Health Diagnostics
Medical
Medical Device
17 Dec 2021 Shenzhen, Guangdong, China

Seppo Biotechnology

Biotechnology
Health Care
Medical Device
01 Jan 2021 Shenzhen, Guangdong, China

celula

Clinical Trials
Manufacturing
Medical Device
$463K09 Oct 2018 Qingyang District, Sichuan, China

Channel Biotechnology

Biotechnology
Health Care
Medical Device
01 Jan 2018 Shenzhen, Guangdong, China

AgTech
Biotechnology
Genetics
Test and Measurement
01 Nov 2016 Shanghai, China
Crunchbase icon

Content report

The following text will be sent to our editors: